Received: 29 May 2020
Accepted: 30 May 2020
First Online: 26 June 2020
Ethics approval and consent to participate
: Approved by Comitato Etico Dell’istituto Nazionale per le Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy, on 21/05/2020; reference number of the ethical approval judgement 124/2020.The Authors certify that this trial has received ethical approval from the appropriate ethical committee as described above.The Investigator at each Centre will ensure that the subject is given full and adequate oral and written information about the nature, purpose, possible risks and benefits of the study. Subjects must also be notified that they are free to discontinue from the study at any time. The subject’s signed and dated informed consent must be obtained prior to conduct any procedure specific for the study. The original signed Written Informed Consent Form must be stored, and a copy must be given to the patient.
: Not applicable.
: The authors declare that they have no competing interests.